Massachusetts Claws Back ABA Payments Over Supervision Ratio

A Year of Payments, Called Back

BOSTON – Massachusetts is trying to take back a year of Medicaid payments from the autism therapy providers it already paid, and the providers have hired lawyers to stop it.

Beginning in late February, MassHealth, the state Medicaid program, directed its contracted insurers to recoup 2024 payments from applied behavior analysis providers that did not keep one hour of supervision by a Licensed Applied Behavior Analyst (LABA), the state license held by board-certified behavior analysts, for every 10 hours of direct therapy. The field calls it the 10-to-1 ratio. Providers that fell far below it were told that every dollar paid for an affected child’s direct services was recoverable.

Many of the notices carried a 30-day deadline to pay. They reached providers through Carelon Behavioral Health, the Elevance Health (NYSE: ELV) unit that administers behavioral benefits for several MassHealth plans. One provider had money withheld from a claims payment a few days before the deadline. The associations representing those providers answered within weeks, with coalition letters, public records requests, and a threat to sue.

At the center of the fight is one question with national reach: can a state treat a clinical supervision guideline as a condition of payment, then enforce it retroactively against claims it already approved and paid? Massachusetts providers, and one of the state’s largest insurers, say no. MassHealth spent roughly $192 million on ABA for more than 9,000 children in fiscal 2023, by the inspector general’s count, so what the state decides to call a payment rule carries real money.

How the Audit Measured Supervision

MassHealth ran 2024 managed care encounter data through a single calculation: the ratio of paid units of CPT 97153, the code for direct behavior therapy delivered by a technician, to paid units of CPT 97155, the code for protocol modification by a licensed clinician that the state counted as supervision. The math was done provider by provider, child by child, across the full calendar year.

The tiers were steep. Providers whose ratio landed between 10-to-1 and 19-to-1, roughly 5 to 10 percent supervision, were billed for the direct-therapy hours above the 10-to-1 line. Providers at 20-to-1 or worse, below 5 percent supervision, were charged for all direct therapy delivered to that child. MassHealth did not flag a single claim as improper. It flagged ratios.

The review covered the six plans that run MassHealth’s ABA benefit: Fallon, Health New England, the Massachusetts Behavioral Health Partnership, WellSense, Tufts Health Plan, and Optum. As of mid-April, notices had gone out through the first four plans while the remaining ones waited.

The insurers had little room to refuse. Under their MassHealth contracts, a plan that failed to collect a flagged overpayment would have the full amount deducted from its capitation, the fixed per-member payments that fund managed care. Disputing the state cost the plan money; collecting from providers did not.

A Guideline, or a Condition of Payment

Provider groups do not argue that supervision is optional. They argue that the 10-to-1 ratio was never a rule they could be made to repay against. In a legal demand letter, attorneys for Massachusetts Providers for ABA Access and Quality (MPAAQ) and the Massachusetts Association of Applied Behavior Analysis (MassABA) called the recoupment “egregiously flawed, both as a matter of substance and process.”

Their statutory argument is specific. Under Massachusetts law, M.G.L. c. 118E, the state may deny a claim more than 12 months after the fact only in narrow circumstances, among them fraud, services not delivered, and noncompliance with MassHealth regulations. The supervision standard, the providers say, lives in performance specifications, not regulations. The state’s own watchdog appears to agree on what those documents are: in its 2024 report, the Office of the Inspector General described performance specifications as “expectations imposed on entities that contract to provide specific ABA services,” not as binding rules.

Then there was the question of which document even applied. When providers asked to see the 2024 performance specifications the audit rested on, neither Carelon nor MassHealth could produce a copy dated to 2024, according to a March 11 coalition letter from MPAAQ, MassABA, and BABAT, a Massachusetts behavior-analysis association. The only version the groups had received was dated January 1, 2025. The 2026 specifications, newly issued, for the first time say supervision ratios are to be measured monthly, a precision the 2024 language did not contain.

“Center-based services are always supervised, with LABA typically within arm’s reach of the behavior technicians.” – Tufts Health Plan, recoupment letter to providers (2026)

A Health Plan Breaks Ranks

The sharpest objection came not from a provider but from a payer. Point32Health, the parent of Tufts Health Plan, filed a formal dispute with MassHealth on February 9, weeks before most providers had seen a letter and months after receiving the state’s overpayment notice the previous November.

Point32Health called the 2024 methodology potentially flawed. It said CPT 97155 was not the only way clinicians document supervision and pointed to H0031-U2, an assessment code, as one the audit ignored. It noted that the governing regulation, 130 CMR 358.00, does not clearly define the supervision requirement. And it said MassHealth had never told plans or providers that only 97155 could prove a licensed analyst supervised a technician. Tufts also warned of double counting, that it could be penalized once through recoupment and again through a 2024 risk-sharing settlement for the same dollars.

The provider coalition layered on technical objections, and all of them pushed the measured ratio the same way, toward apparent noncompliance. ABA is authorized in six-month spans, with supervision running heavier early and lighter later, so a calendar-year average can read a normal cycle as a shortfall. Denied supervision claims dropped out of the numerator even when the supervision happened. Hours a licensed analyst personally delivered were billed as direct therapy and counted as unsupervised time. None of that, the groups argued, meant a child went unsupervised.

What Recoupment Costs Providers

For providers, the bills are not abstract. Massachusetts reimburses roughly $65 an hour for direct ABA, Maria McClain of MassABA told the Legislature’s Joint Committee on Health Care Financing, against about $88 in Arizona and $83 in Maryland. Margins are thin, and a single recoupment can run into six figures.

“If you’re a small provider, and you suddenly have a six-figure recoupment from 2024, you will not make payroll.” – Jim Spink, CEO, Autism Care Partners (2026)

Providers warn that the people squeezed first are low-income families, who already wait longest for care. A clinic that decides MassHealth is no longer worth the risk does not stop serving privately insured children. It stops serving the ones on Medicaid.

A Mechanism Other States Could Copy

What makes Massachusetts worth watching beyond its borders is the method. Rather than audit individual claims for missing notes, the state used a billing ratio as a stand-in for clinical quality and applied it to a full year of paid claims at once. It is a fast, data-driven way to recover money, and it lands as autism therapy becomes a national enforcement target.

Providers say the answer to bad actors is not a retroactive ratio. Massachusetts already requires ABA agencies to earn accreditation from a recognized body, with center-based providers due by January 1, 2027 and the rest by January 1, 2028. The Council of Autism Service Providers (CASP) has urged the state to treat that accreditation, which examines supervision and treatment planning directly, as the real quality check rather than a claims-data proxy.

What Happens Next

Massachusetts has pulled back from an aggressive behavioral-health audit before. In 2018, then-Medicaid director Daniel Tsai ordered the plans to pause audits and suspend uncollected recoupments, citing too little engagement with providers. This time, MassHealth has not publicly answered the litigation threat. The April 2 deadline in the demand letter came and went. The state has said it will meet with the health plans before it sits down with providers, and it has set no date. No recoupment has been formally withdrawn.

AT A GLANCE

SOURCES & REFERENCES